ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Metformin Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38R863
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Metformin Drugs Market Research Report 2020
BUY CHAPTERS

Global Metformin Drugs Market Research Report 2025

Code: QYRE-Auto-38R863
Report
July 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Apotex
Mallinckrodt plc
Teva Pharmaceuticals
Alkem
Dr. Reddy’s Laboratories
Atlas Pharmaceuticals
Sun Pharmaceutical Industries
Torrent Pharmaceuticals
Bristol–Myers Squibb
Viatris

Metformin Drugs Market Size

The global market for Metformin Drugs was valued at US$ 3381 million in the year 2024 and is projected to reach a revised size of US$ 2272 million by 2031, growing at a CAGR of -5.6% during the forecast period.

Metformin Drugs Market

Metformin Drugs Market

Metformin, marketed under the trade name Glucophage among others, is the first-line medication for the treatment of type 2 diabetes, particularly in people who are overweight.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Metformin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metformin Drugs.
The Metformin Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Metformin Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metformin Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Metformin Drugs Market Report

Report Metric Details
Report Name Metformin Drugs Market
Accounted market size in year US$ 3381 million
Forecasted market size in 2031 US$ 2272 million
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 50 Tablets
  • 100 Tablets
  • Other
Segment by Application
  • Hospital
  • Drugs Stores
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Apotex, Viatris, Mallinckrodt, Teva Pharmaceuticals, Alkem, Dr. Reddy’s Laboratories, Atlas Pharmaceuticals, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Bristol-Myers Squibb
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Metformin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Metformin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

What is the Metformin Drugs Market size in 2031?

Ans: The Metformin Drugs Market size in 2031 will be US$ 2272 million.

Who are the main players in the Metformin Drugs Market report?

Ans: The main players in the Metformin Drugs Market are Novartis, Apotex, Viatris, Mallinckrodt, Teva Pharmaceuticals, Alkem, Dr. Reddy’s Laboratories, Atlas Pharmaceuticals, Sun Pharmaceutical Industries, Torrent Pharmaceuticals, Bristol-Myers Squibb

What are the Application segmentation covered in the Metformin Drugs Market report?

Ans: The Applications covered in the Metformin Drugs Market report are Hospital, Drugs Stores

What are the Type segmentation covered in the Metformin Drugs Market report?

Ans: The Types covered in the Metformin Drugs Market report are 50 Tablets, 100 Tablets, Other

Recommended Reports

Diabetes Therapies

Chronic Disease Drugs

Pharmaceutical APIs

1 Metformin Drugs Market Overview
1.1 Product Definition
1.2 Metformin Drugs by Type
1.2.1 Global Metformin Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 50 Tablets
1.2.3 100 Tablets
1.2.4 Other
1.3 Metformin Drugs by Application
1.3.1 Global Metformin Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Drugs Stores
1.4 Global Metformin Drugs Market Size Estimates and Forecasts
1.4.1 Global Metformin Drugs Revenue 2020-2031
1.4.2 Global Metformin Drugs Sales 2020-2031
1.4.3 Global Metformin Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Metformin Drugs Market Competition by Manufacturers
2.1 Global Metformin Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Metformin Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Metformin Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Metformin Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Metformin Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metformin Drugs, Product Type & Application
2.7 Global Key Manufacturers of Metformin Drugs, Date of Enter into This Industry
2.8 Global Metformin Drugs Market Competitive Situation and Trends
2.8.1 Global Metformin Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Metformin Drugs Players Market Share by Revenue
2.8.3 Global Metformin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Metformin Drugs Market Scenario by Region
3.1 Global Metformin Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Metformin Drugs Sales by Region: 2020-2031
3.2.1 Global Metformin Drugs Sales by Region: 2020-2025
3.2.2 Global Metformin Drugs Sales by Region: 2026-2031
3.3 Global Metformin Drugs Revenue by Region: 2020-2031
3.3.1 Global Metformin Drugs Revenue by Region: 2020-2025
3.3.2 Global Metformin Drugs Revenue by Region: 2026-2031
3.4 North America Metformin Drugs Market Facts & Figures by Country
3.4.1 North America Metformin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Metformin Drugs Sales by Country (2020-2031)
3.4.3 North America Metformin Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Metformin Drugs Market Facts & Figures by Country
3.5.1 Europe Metformin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Metformin Drugs Sales by Country (2020-2031)
3.5.3 Europe Metformin Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metformin Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Metformin Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Metformin Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Metformin Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Metformin Drugs Market Facts & Figures by Country
3.7.1 Latin America Metformin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Metformin Drugs Sales by Country (2020-2031)
3.7.3 Latin America Metformin Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metformin Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Metformin Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Metformin Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Metformin Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Metformin Drugs Sales by Type (2020-2031)
4.1.1 Global Metformin Drugs Sales by Type (2020-2025)
4.1.2 Global Metformin Drugs Sales by Type (2026-2031)
4.1.3 Global Metformin Drugs Sales Market Share by Type (2020-2031)
4.2 Global Metformin Drugs Revenue by Type (2020-2031)
4.2.1 Global Metformin Drugs Revenue by Type (2020-2025)
4.2.2 Global Metformin Drugs Revenue by Type (2026-2031)
4.2.3 Global Metformin Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Metformin Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Metformin Drugs Sales by Application (2020-2031)
5.1.1 Global Metformin Drugs Sales by Application (2020-2025)
5.1.2 Global Metformin Drugs Sales by Application (2026-2031)
5.1.3 Global Metformin Drugs Sales Market Share by Application (2020-2031)
5.2 Global Metformin Drugs Revenue by Application (2020-2031)
5.2.1 Global Metformin Drugs Revenue by Application (2020-2025)
5.2.2 Global Metformin Drugs Revenue by Application (2026-2031)
5.2.3 Global Metformin Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Metformin Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis Metformin Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Company Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Apotex Metformin Drugs Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 Viatris
6.3.1 Viatris Company Information
6.3.2 Viatris Description and Business Overview
6.3.3 Viatris Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Viatris Metformin Drugs Product Portfolio
6.3.5 Viatris Recent Developments/Updates
6.4 Mallinckrodt
6.4.1 Mallinckrodt Company Information
6.4.2 Mallinckrodt Description and Business Overview
6.4.3 Mallinckrodt Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mallinckrodt Metformin Drugs Product Portfolio
6.4.5 Mallinckrodt Recent Developments/Updates
6.5 Teva Pharmaceuticals
6.5.1 Teva Pharmaceuticals Company Information
6.5.2 Teva Pharmaceuticals Description and Business Overview
6.5.3 Teva Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharmaceuticals Metformin Drugs Product Portfolio
6.5.5 Teva Pharmaceuticals Recent Developments/Updates
6.6 Alkem
6.6.1 Alkem Company Information
6.6.2 Alkem Description and Business Overview
6.6.3 Alkem Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Alkem Metformin Drugs Product Portfolio
6.6.5 Alkem Recent Developments/Updates
6.7 Dr. Reddy’s Laboratories
6.7.1 Dr. Reddy’s Laboratories Company Information
6.7.2 Dr. Reddy’s Laboratories Description and Business Overview
6.7.3 Dr. Reddy’s Laboratories Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Dr. Reddy’s Laboratories Metformin Drugs Product Portfolio
6.7.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.8 Atlas Pharmaceuticals
6.8.1 Atlas Pharmaceuticals Company Information
6.8.2 Atlas Pharmaceuticals Description and Business Overview
6.8.3 Atlas Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Atlas Pharmaceuticals Metformin Drugs Product Portfolio
6.8.5 Atlas Pharmaceuticals Recent Developments/Updates
6.9 Sun Pharmaceutical Industries
6.9.1 Sun Pharmaceutical Industries Company Information
6.9.2 Sun Pharmaceutical Industries Description and Business Overview
6.9.3 Sun Pharmaceutical Industries Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sun Pharmaceutical Industries Metformin Drugs Product Portfolio
6.9.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.10 Torrent Pharmaceuticals
6.10.1 Torrent Pharmaceuticals Company Information
6.10.2 Torrent Pharmaceuticals Description and Business Overview
6.10.3 Torrent Pharmaceuticals Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Torrent Pharmaceuticals Metformin Drugs Product Portfolio
6.10.5 Torrent Pharmaceuticals Recent Developments/Updates
6.11 Bristol-Myers Squibb
6.11.1 Bristol-Myers Squibb Company Information
6.11.2 Bristol-Myers Squibb Description and Business Overview
6.11.3 Bristol-Myers Squibb Metformin Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Bristol-Myers Squibb Metformin Drugs Product Portfolio
6.11.5 Bristol-Myers Squibb Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metformin Drugs Industry Chain Analysis
7.2 Metformin Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metformin Drugs Production Mode & Process Analysis
7.4 Metformin Drugs Sales and Marketing
7.4.1 Metformin Drugs Sales Channels
7.4.2 Metformin Drugs Distributors
7.5 Metformin Drugs Customer Analysis
8 Metformin Drugs Market Dynamics
8.1 Metformin Drugs Industry Trends
8.2 Metformin Drugs Market Drivers
8.3 Metformin Drugs Market Challenges
8.4 Metformin Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Apotex
Mallinckrodt plc
Teva Pharmaceuticals
Alkem
Dr. Reddy’s Laboratories
Atlas Pharmaceuticals
Sun Pharmaceutical Industries
Torrent Pharmaceuticals
Bristol–Myers Squibb
Viatris
List of Tables
 Table 1. Global Metformin Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Metformin Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Metformin Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Metformin Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Metformin Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Metformin Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Metformin Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Metformin Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Metformin Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Metformin Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Metformin Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Metformin Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Metformin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metformin Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Metformin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Metformin Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Metformin Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Metformin Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Metformin Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Metformin Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Metformin Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Metformin Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Metformin Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Metformin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Metformin Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Metformin Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Metformin Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Metformin Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Metformin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Metformin Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Metformin Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Metformin Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Metformin Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Metformin Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Metformin Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Metformin Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Metformin Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Metformin Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Metformin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Metformin Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Metformin Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Metformin Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Metformin Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Metformin Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Metformin Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Metformin Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Metformin Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Metformin Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Metformin Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Metformin Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Metformin Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Metformin Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Metformin Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Metformin Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Metformin Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Metformin Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Metformin Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Metformin Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Metformin Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Metformin Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Metformin Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Metformin Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Metformin Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Metformin Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Metformin Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Metformin Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Metformin Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Metformin Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. Novartis Company Information
 Table 71. Novartis Description and Business Overview
 Table 72. Novartis Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Novartis Metformin Drugs Product
 Table 74. Novartis Recent Developments/Updates
 Table 75. Apotex Company Information
 Table 76. Apotex Description and Business Overview
 Table 77. Apotex Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Apotex Metformin Drugs Product
 Table 79. Apotex Recent Developments/Updates
 Table 80. Viatris Company Information
 Table 81. Viatris Description and Business Overview
 Table 82. Viatris Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Viatris Metformin Drugs Product
 Table 84. Viatris Recent Developments/Updates
 Table 85. Mallinckrodt Company Information
 Table 86. Mallinckrodt Description and Business Overview
 Table 87. Mallinckrodt Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Mallinckrodt Metformin Drugs Product
 Table 89. Mallinckrodt Recent Developments/Updates
 Table 90. Teva Pharmaceuticals Company Information
 Table 91. Teva Pharmaceuticals Description and Business Overview
 Table 92. Teva Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Pharmaceuticals Metformin Drugs Product
 Table 94. Teva Pharmaceuticals Recent Developments/Updates
 Table 95. Alkem Company Information
 Table 96. Alkem Description and Business Overview
 Table 97. Alkem Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Alkem Metformin Drugs Product
 Table 99. Alkem Recent Developments/Updates
 Table 100. Dr. Reddy’s Laboratories Company Information
 Table 101. Dr. Reddy’s Laboratories Description and Business Overview
 Table 102. Dr. Reddy’s Laboratories Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Dr. Reddy’s Laboratories Metformin Drugs Product
 Table 104. Dr. Reddy’s Laboratories Recent Developments/Updates
 Table 105. Atlas Pharmaceuticals Company Information
 Table 106. Atlas Pharmaceuticals Description and Business Overview
 Table 107. Atlas Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Atlas Pharmaceuticals Metformin Drugs Product
 Table 109. Atlas Pharmaceuticals Recent Developments/Updates
 Table 110. Sun Pharmaceutical Industries Company Information
 Table 111. Sun Pharmaceutical Industries Description and Business Overview
 Table 112. Sun Pharmaceutical Industries Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Sun Pharmaceutical Industries Metformin Drugs Product
 Table 114. Sun Pharmaceutical Industries Recent Developments/Updates
 Table 115. Torrent Pharmaceuticals Company Information
 Table 116. Torrent Pharmaceuticals Description and Business Overview
 Table 117. Torrent Pharmaceuticals Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Torrent Pharmaceuticals Metformin Drugs Product
 Table 119. Torrent Pharmaceuticals Recent Developments/Updates
 Table 120. Bristol-Myers Squibb Company Information
 Table 121. Bristol-Myers Squibb Description and Business Overview
 Table 122. Bristol-Myers Squibb Metformin Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Bristol-Myers Squibb Metformin Drugs Product
 Table 124. Bristol-Myers Squibb Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Metformin Drugs Distributors List
 Table 128. Metformin Drugs Customers List
 Table 129. Metformin Drugs Market Trends
 Table 130. Metformin Drugs Market Drivers
 Table 131. Metformin Drugs Market Challenges
 Table 132. Metformin Drugs Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Metformin Drugs
 Figure 2. Global Metformin Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Metformin Drugs Market Share by Type: 2024 & 2031
 Figure 4. 50 Tablets Product Picture
 Figure 5. 100 Tablets Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Metformin Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Metformin Drugs Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Drugs Stores
 Figure 11. Global Metformin Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Metformin Drugs Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Metformin Drugs Sales (2020-2031) & (K Units)
 Figure 14. Global Metformin Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 15. Metformin Drugs Report Years Considered
 Figure 16. Metformin Drugs Sales Share by Manufacturers in 2024
 Figure 17. Global Metformin Drugs Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Metformin Drugs Players: Market Share by Revenue in Metformin Drugs in 2024
 Figure 19. Metformin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Metformin Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Metformin Drugs Sales Market Share by Country (2020-2031)
 Figure 22. North America Metformin Drugs Revenue Market Share by Country (2020-2031)
 Figure 23. United States Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Metformin Drugs Sales Market Share by Country (2020-2031)
 Figure 26. Europe Metformin Drugs Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Metformin Drugs Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Metformin Drugs Revenue Market Share by Region (2020-2031)
 Figure 34. China Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Metformin Drugs Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Metformin Drugs Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Metformin Drugs Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Metformin Drugs Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Metformin Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Metformin Drugs by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Metformin Drugs by Type (2020-2031)
 Figure 55. Global Metformin Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Metformin Drugs by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Metformin Drugs by Application (2020-2031)
 Figure 58. Global Metformin Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 59. Metformin Drugs Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Metformin Hydrochloride Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Metformin Hydrochloride Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Exenatide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Metformin Hydrochloride Sustained release Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Metformin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metformin Pioglitazone Market Insights Forecast to 2030
Diabetes Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metformin HCl API Market Research Report 2024
Anti diabetic Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Type 2 Diabetes Medications Market Research Report 2024
Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Drugs for Glycogen Metabolism Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Metformin Hydrochloride Sustained release Tablets Market Research Report 2024
Global Metformin Hydrochlorid Market Research Report 2024
Metformin Hydrochloride Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral Medicines for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antidiabetic Agents Market Insights Forecast to 2030
Glycogen Metabolism Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Type 2 Diabetes Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions